The overall goal of this hackathon is to provide hands-on training for the Early Stage Researchers (ESRs) of the REMARO network (but not limited to) on how to architect, program, simulate and ...
Abstract: In this letter we propose a data-driven distributionally robust Model Predictive Control framework for constrained stochastic systems with unbounded additive disturbances. Recursive ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback